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The concentration values of direct and indirect biomarkers of
ethanol consumption were detected in blood (indirect) or hair
(direct) samples from a pool of 125 individuals classified as either
chronic (i.e. positive) and non-chronic (i.e. negative) alcohol
drinkers. These experimental values formed the dataset under
examination (Table 1). Indirect biomarkers included: aspartate
transferase (AST), alanine transferase (ALT), gamma-glutamyl
transferase (GGT), mean corpuscular volume of the erythrocytes
(MCV), carbohydrate-deficient-transferrin (CDT). The following
direct biomarkers were also detected in hair: ethyl myristate
(E14:0), ethyl palmitate (E16:0), ethyl stearate (E18:1), ethyl oleate
(E18:0), the sum of their four concentrations (FAEEs, i.e. Fatty Acid
Ethyl Esters) and ethyl glucuronide (EtG; pg/mg). Body mass index
(BMI) was also collected as a potential influencing factor. Like-
lihood ratio (LR) approaches have been used to provide predictivevier Inc. This is an open access article under the CC BY license
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E. Alladio et al. / Data in Brief 12 (2017) 1–82models for the diagnosis of alcohol abuse, based on different
combinations of direct and indirect alcohol biomarkers, as
described in “Evaluation of direct and indirect ethanol biomarkers
using a likelihood ratio approach to identify chronic alcohol abu-
sers for forensic purposes” (E. Alladio, A. Martyna, A. Salomone,
V. Pirro, M. Vincenti, G. Zadora, 2017) [1].
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Specifications Tableubject area Chemistry
ore specific
subject areaBiomarkers of ethanol consumption in biological samplesype of data Tables, figures
ow data was
acquiredAnalysis by Likelihood Ratio (LR) approach regarding the collected concentration
values of the direct and indirect biomarkers of alcohol consumption.ata format Analyzed
xperimental
factorsCorrect classification rates and Empirical Cross Entropy (ECE) plots [2,3] were
employed to evaluate LR modelsxperimental
featuresAST, ALT and GGT were measured by means of colorimetric assays, MCV was
measured with an on-purpose hematological auto-analyzer, %CDT was deter-
mined by an ad hoc High Performance Liquid Chromatography (HPLC) reagent kit,
FAEEs were detected by HS-SPME-GC/MS analysis and EtG concentrations were
monitored by Ultra High Performance Liquid Chromatography - Tandem Mass
Spectrometry (UHPLC–MS/MS).ata source
locationCentro Regionale Antidoping e di Tossicologia “A. Bertinaria”, Regione Gonzole 10/
1, 10043 Orbassano, Torino, Italy.ata accessibility Data are included in this paperD
Value of the data
 The data reported here represent a valuable collection of all the common biomarkers of alcohol
abuse used worldwide; the distinct populations of chronic and non-chronic alcohol consumers can
possibly be used by other researcher to develop further interpretation models.
 The Empirical Cross Entropy plots provide a novel way to look at the effectiveness of alcohol bio-
markers that other researcher may use for comparison with more traditional data representations.
 The detailed data report allows a clear comparison between univariate, multivariate and Bayesian
approaches, where the latter is suggested as a benchmark for further developments.
 The mathematical background reported in the “materials and methods” section allows other
researcher to transpose the offered approach to different applications.1. Data
Data relative to the population of 125 individuals monitored, previously classified as either chronic
(i.e. positive) and non-chronic (i.e. negative) alcohol drinker, are available in Table 1. Analysis of
likelihood ratio models and its performance metrics, such as Empirical Cross Entropy plots (ECE),
allowed to compare the predictive capabilities of direct and indirect biomarkers of ethanol con-
sumption, as described in [1].
Table 1
Data matrix (12512) containing the concentration values of the reference populations (i.e. individuals labeled as negative or
positive) for the following target analytes: the sum of ethyl myristate, ethyl palmitate, ethyl stearate and ethyl oleate con-
centrations (FAEEs; ng/mg), ethyl glucuronide (EtG; pg/mg), aspartate transferase (AST, IUL1), alanine transferase (ALT;
IUL1), gamma-glutamyl transferase (GGT; IUL1), mean corpuscular volume of the erythrocytes (MCV; fL), carbohydrate-
deficient-transferrin (CDT; %) and body mass index (BMI).
Subject Class FAEEs EtG AST ALT GGT MCV CDT BMI
1 Negative 0.24 24 21 37 39 97.5 1.1 27
2 Negative 0.03 22 24 27 42 93.6 1.1 19
3 Negative 0.34 18 24 20 16 91.4 2.6 27
4 Negative 0.23 11 28 18 34 97.3 1.0 23
5 Negative 0.10 18 20 22 14 87.4 0.7 22
6 Negative 0.07 19 24 31 26 96.4 1.3 26
7 Negative 0.02 17 19 19 17 95.2 1.1 27
8 Negative 0.00 18 18 13 19 92.8 1.2 29
9 Negative 0.16 11 16 22 16 90.6 0.9 26
10 Negative 0.29 15 30 25 102 95.5 0.7 22
11 Negative 0.17 23 19 32 30 91.7 1.9 20
12 Negative 0.34 20 18 15 25 86.9 1.1 17
13 Negative 0.23 14 25 22 16 87.6 1.3 25
14 Negative 0.24 24 29 33 26 91.8 1.4 21
15 Negative 0.27 20 25 39 34 95.6 1.1 28
16 Negative 0.30 15 24 20 27 98.4 1.2 20
17 Negative 0.19 11 20 17 13 87.2 0.9 27
18 Negative 0.14 12 18 18 18 73.7 1.0 23
19 Negative 0.19 15 23 20 38 87.4 1.1 24
20 Negative 0.34 12 20 27 42 88.0 1.0 23
21 Negative 0.09 21 26 24 28 87.3 0.9 25
22 Negative 0.13 14 25 23 17 88.7 0.9 24
23 Negative 0.04 14 25 17 14 95.6 0.7 25
24 Negative 0.37 13 29 32 68 94.0 1.3 23
25 Negative 0.10 12 28 21 15 72.3 1.4 22
26 Negative 0.07 18 18 16 21 96.4 1.2 27
27 Negative 0.11 21 23 21 19 90.2 1.2 24
28 Negative 0.19 11 33 59 21 92.0 1.1 22
29 Negative 0.19 12 26 34 19 88.9 1.0 23
30 Negative 0.20 16 37 24 129 93.4 1.1 28
31 Negative 0.36 13 22 21 16 90.1 1.3 28
32 Negative 0.36 19 19 18 21 85.1 1.2 26
33 Negative 0.36 12 22 20 13 75.6 1.8 23
34 Negative 0.40 23 26 48 25 94.2 0.9 22
35 Negative 0.44 13 25 20 17 94.6 0.9 21
36 Negative 0.05 26 22 10 11 94.9 1.0 25
37 Negative 0.02 1 39 89 35 85.6 1.4 28
38 Negative 0.38 4 35 66 119 90.1 1.1 35
39 Negative 0.00 6 19 18 26 84.7 1.1 25
40 Negative 0.38 4 31 25 91 87.6 1.2 22
41 Negative 0.32 8 41 125 20 88.9 0.8 26
42 Negative 0.09 9 28 59 66 83.1 0.9 27
43 Negative 0.00 2 33 20 17 83.7 0.8 25
44 Negative 0.26 8 23 23 25 58.8 1.0 21
45 Negative 0.00 1 24 42 11 92.6 1.2 25
46 Negative 0.21 1 23 21 19 80.0 1.1 23
47 Negative 0.10 7 35 28 29 93.1 1.1 23
48 Negative 0.11 9 22 27 20 89.1 1.3 27
49 Negative 0.02 9 51 26 19 89.5 0.6 23
50 Negative 0.31 9 22 26 32 88.6 1.1 26
51 Negative 0.12 3 32 43 87 89.7 0.9 27
52 Negative 0.03 7 26 49 57 92.7 1.4 29
53 Negative 0.07 6 25 14 28 95.3 1.0 24
54 Negative 0.07 1 26 35 25 88.9 1.0 23
55 Negative 0.21 3 24 24 30 88.1 1.2 20
56 Negative 0.04 7 23 29 51 89.4 1.1 26
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Table 1 (continued )
Subject Class FAEEs EtG AST ALT GGT MCV CDT BMI
57 Negative 0.02 1 25 26 37 89.9 1.1 27
58 Negative 0.03 4 20 16 14 87.8 0.9 22
59 Negative 0.21 7 18 14 16 95.3 1.2 25
60 Negative 0.31 5 22 23 15 92.7 1.1 21
61 Negative 0.42 8 35 40 21 92.7 1.0 23
62 Negative 0.00 2 18 11 16 92.1 0.7 19
63 Negative 0.22 3 20 24 33 87.5 1.2 29
64 Negative 0.06 2 24 27 28 87.5 1.0 24
65 Negative 0.09 4 32 17 15 97.8 1.1 21
66 Negative 0.26 7 25 21 14 88.9 1.1 21
67 Negative 0.05 9 30 35 17 99.1 1.0 21
68 Negative 0.09 9 20 15 18 88.2 1.6 22
69 Negative 0.01 1 49 42 82 91.7 0.6 24
70 Negative 0.02 1 24 21 20 92.0 0.9 24
71 Negative 0.10 2 18 17 23 88.4 0.9 21
72 Negative 0.16 8 22 30 43 90.1 1.1 43
73 Negative 0.37 3 31 31 21 91.1 0.8 21
74 Negative 0.04 1 26 24 13 89.8 0.9 23
75 Negative 0.13 4 27 34 45 84.9 1.1 31
76 Negative 0.25 8 32 51 33 88.8 1.3 29
77 Negative 0.10 6 31 32 55 88.5 1.2 27
78 Negative 0.15 2 23 32 33 83.9 0.9 28
79 Negative 0.01 1 27 38 43 93.1 1.5 26
80 Negative 0.25 6 20 16 11 90.3 1.2 19
81 Negative 0.14 6 24 20 24 93.1 1.1 28
82 Negative 0.35 4 17 18 16 89.6 0.9 28
83 Negative 0.16 7 19 23 21 92.0 0.7 19
84 Negative 0.16 1 42 88 116 92.6 0.9 29
85 Negative 0.15 2 23 16 29 98.9 1.7 20
86 Negative 0.02 9 32 49 30 97.6 0.8 19
87 Negative 0.25 8 27 28 18 98.0 0.8 23
88 Negative 0.00 3 18 25 25 90.1 0.9 22
89 Negative 0.12 5 25 17 15 85.5 1.0 24
90 Negative 0.01 9 33 28 23 95.7 1.0 27
91 Negative 0.13 5 30 23 15 91.9 0.8 19
92 Negative 0.20 1 22 24 34 91.1 1.5 24
93 Negative 0.19 2 24 17 21 92.5 0.7 19
94 Negative 0.02 5 50 86 32 90.8 0.9 22
95 Negative 0.09 1 34 42 22 93.9 1.3 27
96 Negative 0.02 8 33 26 20 84.8 1.1 25
97 Positive 0.52 43 23 21 45 63.4 1.7 28
98 Positive 0.92 38 27 23 16 92.7 1.0 27
99 Positive 0.57 36 37 65 78 98.8 1.3 26
100 Positive 0.93 52 31 21 20 99.1 1.5 25
101 Positive 2.05 35 29 40 135 94.0 2.0 31
102 Positive 1.22 56 29 35 102 97.1 1.0 30
103 Positive 3.19 52 40 73 41 91.6 1.4 25
104 Positive 1.56 43 39 30 17 92.0 0.9 19
105 Positive 1.30 52 17 11 18 93.7 1.5 18
106 Positive 1.35 38 41 53 39 95.5 4.8 26
107 Positive 0.51 36 19 15 12 92.0 1.2 21
108 Positive 0.51 60 28 42 35 65.3 1.8 28
109 Positive 4.50 79 27 25 25 88.7 1.4 26
110 Positive 1.42 38 23 9 24 97.2 1.0 25
111 Positive 1.37 41 22 21 26 91.1 0.9 22
112 Positive 2.98 37 21 19 22 87.1 1.6 23
113 Positive 6.44 106 25 28 23 96.8 1.1 23
114 Positive 3.17 33 21 15 14 98.4 0.8 24
115 Positive 0.98 54 26 37 67 89.8 1.2 24
116 Positive 0.57 93 22 24 27 93.6 0.9 26
117 Positive 2.25 32 27 31 14 87.0 0.8 24
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Table 1 (continued )
Subject Class FAEEs EtG AST ALT GGT MCV CDT BMI
118 Positive 0.69 65 25 18 42 93.8 1.1 25
119 Positive 2.45 68 19 14 20 95.0 0.9 21
120 Positive 2.10 95 65 114 97 97.7 1.3 27
121 Positive 1.25 90 26 11 23 94.5 4.2 29
122 Positive 1.03 38 52 39 202 106.5 1.0 27
123 Positive 5.84 35 28 43 160 96.8 1.4 28
124 Positive 2.04 119 25 20 58 98.5 2.0 23
125 Positive 2.02 18 19 13 21 93.0 1.9 19
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Ethical approval for the study was granted by the Ethical Committee of the Azienda Ospedaliero-
Universitaria San Luigi Gonzaga of Orbassano (Protocol Number 0012756). Serum activities of AST,
ALT and GGT were measured by means of colorimetric assays with a Roche-Cobas Integra 800
s
auto-
analyzer (Roche Diagnostic, Basel, Switzerland). MCV was measured with an ADVIA
s
2120 Hema-
tology auto-analyzer (Siemens Healthcare Diagnostic, Milan, Italy). The %CDT was determined by the
HPLC reagent kit purchased by BioRad
s
(Munich, Germany). FAEEs were detected by HS–SPME–GC/
MS analysis and a MultiPurpose Sampler Flex A05-FLX-0001 (Est Analytical, West Chester Township,
OH, USA) equipped with a 65 μm StableflexTM polydimethylsiloxane/divinylbenzene fiber (PDMS/
DVB) from Supelco (Sigma-Aldrich, Milan, Italy) was used in combination with a 6890N GC 5975-inert
MSD (Agilent Technologies, Milan, Italy). EtG concentrations were monitored by UHPLC–MS/MS
analysis and a Shimadzu Nexera UHPLC system (Shimadzu, Duisburg, Germany) interfaced to an AB
Sciex API 5500 triple quadrupole mass spectrometer (AB Sciex, Darmstadt, Germany) was employed.
Descriptions about the analytical methodologies utilized to detect both the direct and the indirect
biomarkers are available in [1] and [4].
Base 10 logarithm transformation (log10x) was applied on the analyzed data. Before calculating the
different LR models, all the variables were autoscaled and equal prior probabilities were utilized. LR
evaluations (briefly represented by this formula LR¼Pr(E|H1)/Pr(E|H2)) involved two mutually
exclusive hypotheses (H1: the subject is not a chronic alcohol abuser – “negative” class; H2: the
subject is a chronic alcohol abuser – “positive” class) and a reference population was used to build the
model, representing the experimental evidence (E). The ECE plots relative to indirect biomarkers
detected in blood samples are reported in Fig. 1.
ECE plots relative to the sum of the four FAEEs and EtG are reported in [1]. Further LR models were
tested combining biomarkers, providing higher performances. As an example, LR models developed
taking into account all the variables simultaneously (LR8, i.e. AST, ALT, GGT, CDT, MCV, BMI, FAEEs and
EtG) and a shorter list of variables (LR4, i.e. CDT, GGT, FAEEs and EtG) are shown in Fig. 2a–b.
Multivariate approaches were also performed on the collected data simultaneously; Principal
Components Analysis [5] (PCA, Fig. 3a) and Partial Least Squares – Discriminant Analysis [6] (PLS-DA,
Fig. 3b).
The formulas employed, together with the description of ECE plots, are reported in Supplementary
material.
Fig. 1. The ECE plots describing the performance of univariate LR models relative to ALT (a), AST (b), CDT (c) and GGT (d), MCV
(e) and BMI (f) variables. These plots suggest that the indirect biomarkers detected in blood samples prove inadequate to
provide clear discrimination between chronic from non-chronic alcohol consumers, as measured by both correct classification
rates and ECE plots.
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Fig. 3. The PCA(a) and PLS-DA (b) Score Plots: chronic alcohol drinkers are represented by red diamonds, while non-chronic
alcohol drinkers are indicated by green squares.
Fig. 2. The ECE plots describing the performance of LR models relative to all the variables (LR8)(a) and CDT, GGT, FAEEs and EtG
only (LR4) (b).
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